Company Filing History:
Years Active: 2011-2019
Title: The Innovative Contributions of Xianfu Wu
Introduction
Xianfu Wu is a prominent inventor based in Atlanta, GA, known for his significant contributions to the field of virology. With a total of 7 patents, he has made remarkable strides in the identification and treatment of lyssaviruses, particularly in relation to rabies.
Latest Patents
Wu's latest patents include groundbreaking methods for identifying antibodies specific for lyssaviruses. One notable patent describes a method of identifying a monoclonal antibody that specifically binds to a plurality of lyssaviruses for use in post-exposure rabies prophylaxis or in the treatment of clinical rabies. This method utilizes a naïve antibody phage display library to screen for phage clones that bind to whole recombinant rabies virus or cells expressing glycoprotein from multiple lyssaviruses, such as RABV, MOKV, and WCBV. Another patent focuses on the identification of antibodies specific for at least two different lyssaviruses, further enhancing the potential for effective treatments against rabies.
Career Highlights
Xianfu Wu is currently affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His work at this esteemed institution has allowed him to focus on innovative research that addresses critical health challenges posed by lyssaviruses.
Collaborations
Wu has collaborated with notable colleagues in his field, including Charles E. Rupprecht and Todd G. Smith. These partnerships have contributed to the advancement of research and the development of effective therapeutic strategies against rabies.
Conclusion
Xianfu Wu's innovative work in identifying antibodies for lyssaviruses has the potential to significantly impact public health, particularly in the prevention and treatment of rabies. His contributions to science and medicine are invaluable and continue to pave the way for future advancements in virology.